Atlas Trials

MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC

Clinical trial NCT07235566 · RECRUITING

Trial details

NCT number
NCT07235566
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Thyroid Cancer
Start date
2025-04-21
Primary completion
2029-04-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.